Skip to content

Drug interactions

Elagolix + Ribociclib

Severity: Moderate

Elagolix and Ribociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak-to-moderate CYP3A4 inducer, which may lower ribociclib concentrations and reduce its antitumor effect. Ribociclib may in turn raise elagolix exposure. Elagolix is generally used in non-oncology settings, so concurrent use is uncommon.

What this interaction means in plain words

Elagolix and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Ribociclib belongs to Oncology.

Evidence level: Low

Why it happens

Elagolix induces CYP3A4, lowering ribociclib exposure, while ribociclib inhibits CYP3A4 and may raise elagolix levels.

What to do

Review whether elagolix is needed; if combined, monitor for reduced ribociclib efficacy and elagolix adverse effects such as bone loss.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Ribociclib?

MediHelp rates the interaction as moderate. Elagolix and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a weak-to-moderate CYP3A4 inducer, which may lower ribociclib concentrations and reduce its antitumor effect. Ribociclib may in turn raise elagolix exposure. Elagolix is generally used in non-oncology settings, so concurrent use is uncommon.

How serious is the interaction between Elagolix and Ribociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Review whether elagolix is needed; if combined, monitor for reduced ribociclib efficacy and elagolix adverse effects such as bone loss.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in